iShares Evolved U.S. Innovative Healthcare ETF (IEIH)
|Ex-Dividend Date||Jun 9, 2022|
|Day's Range||34.12 - 34.31|
|Inception Date||Mar 21, 2018|
The fund invests, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies. It will hold common stock of those companies that fall into the Innovative Healthcare Evolved Sector which have economic characteristics that have been historically correlated with companies traditionally defined as pharmaceutical and biotechnology companies. The fund is non-diversified.
Top 10 Holdings59.34% of assets
|Johnson & Johnson||JNJ||9.83%|
|BLK CSH FND TREASURY SL AGENCY||XTSLA||8.02%|
|Eli Lilly and Company||LLY||6.75%|
|Merck & Co.||MRK||5.53%|
|Bristol-Myers Squibb Company||BMY||5.13%|
|Jun 9, 2022||$0.08184||Jun 15, 2022|
|Mar 24, 2022||$0.14879||Mar 30, 2022|
|Dec 13, 2021||$0.60844||Dec 17, 2021|
|Sep 24, 2021||$0.12464||Sep 30, 2021|
|Jun 10, 2021||$0.08647||Jun 16, 2021|
|Mar 25, 2021||$0.10641||Mar 31, 2021|
Johnson & Johnson continued its long streak of earnings beat. It outpaced revenue estimates as well but cut its full-year guidance on a strong dollar.
NEW YORK--(BUSINESS WIRE)--iShares today announced its plans to close the following U.S. -listed ETFs on August 25, 2022. Ticker Fund Name AGT iShares MSCI Argentina and Global Exposure ETF EMBH iShares...
The pandemic-driven supply chain woes and the resultant red-hot inflation, the Russia-Ukraine war and the resultant hit to the commodity market as well as the central banks' policy tightening in the dev...
Uncertainties are playing a big role in the Wall Street due to record-high inflation, Fed policy tightening and Omicron strain of coronavirus. Still, some ETFs may warm up your winter portfolio.
The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.
Upbeat earnings, COVID-19-related sales, compelling valuation and lucrative dividend prospects are boosting pharma and healthcare ETFs.
Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administration r...
Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.
Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.
Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.